{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T15:34:09Z","timestamp":1768923249612,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,11,16]],"date-time":"2014-11-16T00:00:00Z","timestamp":1416096000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s00417-014-2851-8","type":"journal-article","created":{"date-parts":[[2014,11,15]],"date-time":"2014-11-15T03:38:24Z","timestamp":1416022704000},"page":"287-294","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Three-year corneal graft survival rate in high-risk cases treated with subconjunctival and topical bevacizumab"],"prefix":"10.1007","volume":"253","author":[{"given":"Iva","family":"Dekaris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikica","family":"Gabri\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nata\u0161a","family":"Dra\u010da","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"Pauk-Guli\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neven","family":"Mili\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,16]]},"reference":[{"key":"2851_CR1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1615\/CritRevImmunol.v18.i4.20","volume":"18","author":"G Rocha","year":"1998","unstructured":"Rocha G, Deschenes J, Rowsey JJ (1998) The immunology of corneal graft rejection. Crit Rev Immunol 18:305\u2013325","journal-title":"Crit Rev Immunol"},{"key":"2851_CR2","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/archopht.1992.01080220054021","volume":"110","author":"The Collaborative Corneal Transplantation Studies (CCTS)","year":"1992","unstructured":"The Collaborative Corneal Transplantation Studies (CCTS) (1992) Effectiveness of histocompatibility matching in high-risk corneal transplantation. The Collaborative Corneal Transplantation Studies Research Group. Arch Ophthalmol 110:1392\u20131403","journal-title":"Arch Ophthalmol"},{"key":"2851_CR3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/08820530500509358","volume":"21","author":"MR Dana","year":"2006","unstructured":"Dana MR (2006) Angiogenesis and lymphangiogenesis\u2014implications for corneal immunity. Semin Ophthalmol 21:19\u201322","journal-title":"Semin Ophthalmol"},{"key":"2851_CR4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archopht.126.1.71","volume":"126","author":"BO Bachmann","year":"2008","unstructured":"Bachmann BO, Bock F, Wiegand SJ, Maruyama K, Dana MR, Kruse FE, Luetjen-Drecoll E, Cursiefen C (2008) Promotion of graft survival by vascular endothelial growth factor neutralization after high-risk corneal transplantation. Arch Ophthalmol 126:71\u201377","journal-title":"Arch Ophthalmol"},{"key":"2851_CR5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.12669\/pjms.292.3089","volume":"29","author":"N Bhatti","year":"2013","unstructured":"Bhatti N, Qidwai U, Hussain M, Kazi A (2013) Efficacy of topical bevacizumab in high-risk corneal transplant survival. Pak J Med Sci 29:519\u2013522","journal-title":"Pak J Med Sci"},{"key":"2851_CR6","first-page":"1256","volume":"63","author":"N Bhatti","year":"2013","unstructured":"Bhatti N, Qidwai U, Hussain M, Kazi A (2013) Efficacy of sub-conjunctival and topical bevacizumab in high-risk corneal transplant survival. J Pak Med Assoc 63:1256\u20131259","journal-title":"J Pak Med Assoc"},{"key":"2851_CR7","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00417-009-1170-y","volume":"247","author":"PI Vassileva","year":"2009","unstructured":"Vassileva PI, Hergeldzhieva TG (2009) Avastin use in high risk corneal transplantation. Graefes Arch Clin Exp Ophthalmol 247:1701\u20131706","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2851_CR8","first-page":"264","volume":"104","author":"DT Azar","year":"2006","unstructured":"Azar DT (2006) Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc 104:264\u2013302","journal-title":"Trans Am Ophthalmol Soc"},{"key":"2851_CR9","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","volume":"12","author":"JH Chang","year":"2001","unstructured":"Chang JH, Gabison EE, Kato T, Azar DT (2001) Corneal neovascularization. Curr Opin Ophthalmol 12:242\u2013249","journal-title":"Curr Opin Ophthalmol"},{"key":"2851_CR10","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s004170100313","volume":"239","author":"C Cursiefen","year":"2001","unstructured":"Cursiefen C, Wenkel H, Martus P, Langenbucher A, Nguyen NX, Seitz B, K\u00fcchle M, Naumann GO (2001) Impact of short-term versus long-term topical steroids on corneal neovascularization after non-high-risk keratoplasty. Graefes Arch Clin Exp Ophthalmol 239:514\u2013521","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"2851_CR11","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1097\/ICO.0b013e3182a2c937","volume":"32","author":"M Shimmura-Tomita","year":"2013","unstructured":"Shimmura-Tomita M, Shimmura S, Satake Y, Shimazaki-Den S, Omoto M, Tsubota K, Shimazaki J (2013) Keratoplasty postoperative treatment update. Cornea 32(1):S60\u201364","journal-title":"Cornea"},{"issue":"1","key":"2851_CR12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1055\/s-2008-1027127","volume":"225","author":"D Bohringer","year":"2008","unstructured":"Bohringer D, Reinhard T (2008) Prognosis in repeat keratoplasty: per indication analysis in a large monocentric cohort. Klin Monatsbl Augenheilkd 225(1):50\u201356","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"2851_CR13","first-page":"1","volume":"5","author":"M B\u00e4umler","year":"2014","unstructured":"B\u00e4umler M, Sundmacher L, Reinhard T, B\u00f6hringer D (2014) Cost-effectiveness of human leukocyte antigen matching in penetrating keratoplasty. Int J Technol Assess Health Care 5:1\u20139","journal-title":"Int J Technol Assess Health Care"},{"issue":"3","key":"2851_CR14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10792-007-9100-7","volume":"28","author":"KF Tabbara","year":"2008","unstructured":"Tabbara KF (2008) Pharmacologic strategies in the prevention and treatment of corneal transplant rejection. Int Ophthalmol 28(3):223\u2013232","journal-title":"Int Ophthalmol"},{"issue":"2","key":"2851_CR15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ajo.2010.03.010","volume":"150","author":"MA Chatel","year":"2010","unstructured":"Chatel MA, Larkin DF (2010) Sirolimus and mycophenolate as combination prophylaxis in corneal transplant recipients at high rejection risk. Am J Ophthalmol 150(2):179\u2013184","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"2851_CR16","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1136\/bjophthalmol-2013-303639","volume":"97","author":"OA Magalhaes","year":"2013","unstructured":"Magalhaes OA, Marinho DR, Kwitko S (2013) Topical 0.03\u00a0% tacrolimus preventing rejection in high-risk corneal transplantation: a cohort study. Br J Ophthalmol 97(11):1395\u20131398","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"2851_CR17","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ophtha.2012.09.035","volume":"120","author":"W Shi","year":"2013","unstructured":"Shi W, Chen M, Xie L, Liu M, Gao H, Wang T, Wu X, Zhao J (2013) A novel cyclosporine A drug-delivery system for prevention of human corneal rejection after high-risk keratoplasty: a clinical study. Ophthalmology 120(4):695\u2013702","journal-title":"Ophthalmology"},{"key":"2851_CR18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0195-27","volume":"1","author":"J Folkman","year":"1995","unstructured":"Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27\u201331","journal-title":"Nat Med"},{"key":"2851_CR19","first-page":"18","volume":"39","author":"S Amano","year":"1998","unstructured":"Amano S, Rohan R, Kuroki M, Tolentino M, Adamis AP (1998) Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. Invest Ophthalmol Vis Sci 39:18\u201322","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2851_CR20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jtos.2012.01.005","volume":"10","author":"W Stevenson","year":"2012","unstructured":"Stevenson W, Cheng S, Dastjerdi M, Ferrari G, Dana R (2012) Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin). Ocul Surf 10:67\u201383","journal-title":"Ocul Surf"},{"issue":"10","key":"2851_CR21","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.ophtha.2006.05.064","volume":"113","author":"RL Avery","year":"2006","unstructured":"Avery RL, Pearlman J, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ, Wendel R, Patel A (2006) Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 113(10):1695","journal-title":"Ophthalmology"},{"key":"2851_CR22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ophtha.2005.11.019","volume":"113","author":"RL Avery","year":"2006","unstructured":"Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ (2006) Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113:363\u2013372","journal-title":"Ophthalmology"},{"key":"2851_CR23","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s00347-007-1512-2","volume":"104","author":"F Bock","year":"2007","unstructured":"Bock F, K\u00f6nig Y, Dietrich T, Zimmermann P, Baier M, Cursiefen C (2007) Inhibition of angiogenesis in the anterior chamber of the eye. Ophtalmologe 104:336\u2013344","journal-title":"Ophtalmologe"},{"key":"2851_CR24","doi-asserted-by":"crossref","unstructured":"Fasciani R, Mosca L, Giannico MI, Ambrogio SA, Balestrazzi E (2014). Subconjunctival and\/or intrastromal bevacizumab injections as preconditioning therapy to promote corneal graft survival. Int Ophthalmol Apr 9 [Epub ahead of print]","DOI":"10.1007\/s10792-014-9938-4"},{"issue":"11","key":"2851_CR25","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s00417-012-1988-6","volume":"250","author":"AE Altenburger","year":"2012","unstructured":"Altenburger AE, Bachmann B, Seitz B, Cursiefen C (2012) Morphometric analysis of postoperative corneal neovascularization after high-risk keratoplasty: herpetic versus non-herpetic disease. Graefes Arch Clin Exp Ophthalmol 250(11):1663\u20131671","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"8","key":"2851_CR26","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/bjo.84.8.813","volume":"84","author":"A Waldock","year":"2000","unstructured":"Waldock A, Cook SD (2000) Corneal transplantation: how successful are we? Br J Ophthalmol 84(8):813\u2013815","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"2851_CR27","first-page":"425","volume":"149","author":"SE Hern\u00e1ndez-Da Mota","year":"2013","unstructured":"Hern\u00e1ndez-Da Mota SE, Paniagua Jacobo M, G\u00f3mez Revuelta G, P\u00e1ez Mart\u00ednez RM (2013) Corneal transplant in a second level hospital. A survival analysis. Gac Med Mex 149(4):425\u2013430","journal-title":"Gac Med Mex"},{"key":"2851_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/02713683.2014.925935","volume":"9","author":"S Sekelj","year":"2014","unstructured":"Sekelj S, Dekaris I, Balog T, Mahovne I, Krstonijevic EK, Janjetovic Z, Arar ZV, Aric I (2014) Vascular endothelial growth factor in a recipient cornea acts as a prognostic factor for corneal graft reactiondevelopment. Curr Eye Res 9:1\u20138","journal-title":"Curr Eye Res"},{"issue":"12","key":"2851_CR29","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1097\/ICO.0b013e31821e65b3","volume":"30","author":"AK Maier","year":"2011","unstructured":"Maier AK, Ozlugedik S, Rottler J, Heussen FM, Klamann MK, Huber KK, Joussen AM, Winterhalter S (2011) Efficacy of postoperative immunosuppression after keratoplasty in herpetic keratitis. Cornea 30(12):1398\u2013405","journal-title":"Cornea"},{"issue":"1","key":"2851_CR30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ajo.2011.05.020","volume":"153","author":"V Scorcia","year":"2012","unstructured":"Scorcia V, Busin M (2012) Survival of mushroom keratoplasty performed in corneas with postinfectious vascularised scars. Am J Ophthalmol 153(1):44\u201350","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"2851_CR31","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1097\/ICO.0b013e31823f8e95","volume":"31","author":"CC Chan","year":"2012","unstructured":"Chan CC, Biber JM, Holland EJ (2012) The modified Cincinnati procedure: combined conjunctival limbal autografts and keratolimbal allografts for severe unilateral ocular surface failure. Cornea 31(11):1264\u20131272","journal-title":"Cornea"},{"issue":"7","key":"2851_CR32","first-page":"710","volume":"26","author":"V Borderie","year":"2003","unstructured":"Borderie V, Touzeau O, Bourcier T, Allouch C, Scheer S, Laroche L (2003) Treatment of the sequelae of ocular burns using limbal transplantation. J Fr Ophtalmol 26(7):710\u2013716","journal-title":"J Fr Ophtalmol"},{"issue":"3","key":"2851_CR33","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/112067210901900306","volume":"19","author":"Z Yalniz-Akkaya","year":"2009","unstructured":"Yalniz-Akkaya Z, Burcu Nurozler A, Yildiz E, Onat M, Budak K, Duman S (2009) Repeat penetrating keratoplasty: indications and prognosis, 1995\u20132005. Eur J Ophthalmol 19(3):362\u2013368","journal-title":"Eur J Ophthalmol"},{"key":"2851_CR34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/bjo.87.1.101","volume":"87","author":"C Cursiefen","year":"2003","unstructured":"Cursiefen C, Hofmann-Rummelt C, K\u00fcchle M, Schl\u00f6tzer-Schrehardt U (2003) Pericyte recruitment in human corneal angiogenesis: an ultrastructural study with clinicopathological correlation. Br J Ophthalmol 87:101\u2013106","journal-title":"Br J Ophthalmol"},{"key":"2851_CR35","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00417-009-1099-1","volume":"247","author":"Y Koenig","year":"2009","unstructured":"Koenig Y, Bock F, Horn F, Straub K, Cursiefen C (2009) Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization. Graefes Arch Clin Exp Ophthalmol 247:1375\u20131382","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2851_CR36","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.ajo.2012.06.007","volume":"154","author":"SF Cheng","year":"2012","unstructured":"Cheng SF, Dastjerdi MH, Ferrari G, Okanobo A, Bower KS, Ryan DS, Amparo F, Stevenson W, Hamrah P, Nallasamy N, Dana R (2012) Short-term topical bevacizumab in the treatment of stable corneal neovascularization. Am J Ophthalmol 154:940\u2013948","journal-title":"Am J Ophthalmol"},{"key":"2851_CR37","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.ophtha.2008.02.013","volume":"115","author":"SW Kim","year":"2008","unstructured":"Kim SW, Ha BJ, Kim EK, Tchah H, Kim TI (2008) The effect of topical bevacizumab on corneal neovascularization. Ophthalmology 115:e33\u2013e38","journal-title":"Ophthalmology"},{"key":"2851_CR38","first-page":"3339","volume":"17","author":"R Rusovici","year":"2011","unstructured":"Rusovici R, Sakhalkar M, Chalam KV (2011) Evaluation of cytotoxicity of bevacizumab on VEGF-enriched corneal endothelial cells. Mol Vis 17:3339\u20133346","journal-title":"Mol Vis"},{"issue":"3","key":"2851_CR39","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10792-013-9807-6","volume":"34","author":"A Lichtinger","year":"2014","unstructured":"Lichtinger A, Yeung SN, Kim P, Amiran MD, Elbaz U, Slomovic AR (2014) Corneal endothelial safety following subconjunctivaly and intrastromal injection of bevacizumab for corneal neovascularization. Int Ophthalmol 34(3):597\u2013601","journal-title":"Int Ophthalmol"},{"issue":"2","key":"2851_CR40","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00417-013-2495-0","volume":"252","author":"E Moisseiev","year":"2014","unstructured":"Moisseiev E, Waisburd M, Ben-Arsti E, Levinger E, Barak A, Daniels T, Csaky K, Loewenstein A, Barequet IS (2014) Pharamacokinetics of bevacizumab after topical and intravitreal administration in human eyes. Graefes Arch Clin Exp Ophthalmol 252(2):331\u2013337","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-014-2851-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-014-2851-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-014-2851-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T12:20:02Z","timestamp":1566044402000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-014-2851-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,16]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["2851"],"URL":"https:\/\/doi.org\/10.1007\/s00417-014-2851-8","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,16]]}}}